PVP Ventures began as a Chennai real-estate developer in 1991, but since 2023 it has been dismantling that old conglomerate to rebuild itself as a healthcare-services platform - a partner-led aggregator that buys majority stakes in profitable, regional healthcare brands and gives them shared systems and growth capital while the founders keep running the operations. The recurring approach is simple: sell the legacy land, use the cash to acquire specialised providers in underserved markets, and let each one keep its own name and entrepreneurial drive inside a common ‘House of Brands’. The company is so far down this road that in May 2026 its board approved renaming it from PVP Ventures to Evervie Health.
Business segments
Three engines at different stages - a legacy land bank that throws off predictable cash, a hospitality operation, and a healthcare platform being assembled acquisition by acquisition - each funded by the one before it.
1. Legacy real estate: the cash engine that funds the healthcare pivot
A 70-acre land parcel in North Chennai is being monetised through joint-development agreements with three established builders, generating contracted revenue shares without PVP spending a rupee on construction.
- Land bank, not a builder - the company owns roughly 70 acres of proprietary land in Perambur, North Chennai, and has moved away from developing projects itself; instead it signs Joint Development Agreements (JDAs) where the developer bears all costs and PVP collects a fixed share of every sale.
- Three pools of predictable cash - the land has been split across three developers. Rainbow Foundations is finishing a 34-acre project where 2,000 families already live, with residual sales expected to bring PVP about Rs. 100 Crores over FY24-26. Casa Grande is developing 12 acres and is expected to deliver over INR 500 Crores over five years. Brigade Enterprises is developing 16 acres - over 2.5 million square feet of residential inventory - and PVP is contracted to receive 40% of the entire project’s revenue, expected to exceed INR 1,200 Crores over a six year timeframe.
- Cash already unlocked - the company has already unlocked ₹600 crore through these JDAs to fuel its healthcare acquisitions.
2. Hospitality: a steady operating business alongside the land
The company runs a hospitality operation that contributes roughly a third of its revenue, though the dossiers treat it as a supporting line rather than the strategic centrepiece.
- A meaningful contributor - the hospitality segment accounts for about 32% of the company’s revenue mix, sitting between the legacy real-estate cash flows and the emerging healthcare platform (Segment mix context).
- Operational detail is thin - the dossiers do not describe the nature, brand, location or scale of the hospitality assets, only that the segment exists and generates revenue alongside real estate and the newer healthcare ventures.
3. Healthcare services: the future, built one acquisition at a time
PVP buys majority stakes in profitable, founder-led healthcare businesses focused on Tier-2 and Tier-3 cities - cancer care, renal care, diagnostics and senior care - and wraps them in a shared platform that supplies cheaper sourcing, digital tools and growth capital while each brand keeps its own name and operational independence.
- A ‘House of Brands’, not a chain - the company acquires 52-56% stakes in regionally leading providers, leaves the founding entrepreneurs in charge of day-to-day operations, and layers on centralised capabilities: bulk purchasing that cuts equipment and consumable costs by 3-5% from day one, shared IT and digital infrastructure, and a commercial team that helps founders break through growth barriers.
- Cancer care in small-town Maharashtra - the oncology vertical was built by acquiring a 56% stake in Optimus Oncology, founded by radiation oncologists trained at Tata Memorial Hospital; it runs radiation therapy centres in Tier-2 and Tier-3 towns in Maharashtra and was bought for a total investment of about INR 55 crore via a mix of primary capital and buying out existing shareholders.
- Dialysis and kidney hospitals across six states - the renal-care vertical came through a majority-stake acquisition of 7Med India (Epitome Group of Hospitals), which operates 22 centres - shop-in-shop dialysis units inside leading hospitals plus standalone facilities - and four super-specialty nephrology and urology hospitals across six states, employing over 450 professionals and ranking among India’s top five organised renal-care players. PVP acquired 41.2% in two tranches by July 2026, with a contracted path to 50.62% within twelve months of the August 2025 agreement and a roadmap to 76% over time, for a total outlay of about INR 127 crore.
- Diagnostics with a Tier-2 focus - the diagnostics vertical was expanded by buying a 52% stake in Biohygea Global (brand name Medilabs), founded in 2014 by a radiologist and a hospital-operations veteran. Medilabs runs its own diagnostic centres with CT and ultrasound imaging and a test menu of over 1,500 tests, and also sets up labs inside partner hospitals, with a stated focus on fetal medicine, genomics and oncology testing in smaller cities and towns.
- Senior care on the horizon - the company has a stated plan to acquire senior-care platforms in the United Kingdom under ‘Project Thistle UK’, focusing on senior living and dementia care, and in May 2026 the board approved forming an international holding company to pursue healthcare expansion in the Middle East and the UK.
Group structure and partners
A listed holding company that has spent three years stripping away its old conglomerate layers - media, NBFC, cyber-city projects - to become a clean healthcare platform with a promoter group holding over 54% and a fresh set of operating subsidiaries in diagnostics, oncology and renal care.
- The old conglomerate has been cut away - between 2022 and 2023 the company merged three wholly-owned subsidiaries (real estate, safety lockers, media) into itself, then sold its media subsidiary, its global ventures arm, and 81% of a material cyber-city subsidiary to promoter-group entities, booking a gain of Rs 320 million on one divestment and later selling its residual 6.36% stake in Picturehouse Media to a promoter for Rs. 2.20 Crores.
- The NBFC legacy is being wound down - the step-down subsidiary PVP Capital Limited, an NBFC that lent to film production, defaulted on bank loans and settled with Canara Bank for INR 95 Crores in March 2022; it has not maintained the minimum net owned funds required by RBI regulations.
- Today’s structure is simpler - as of FY25 the listed entity’s subsidiaries include the legacy PVP Corporate Parks, the healthcare operating companies Humain Healthtech (100%), Biohygea Global/Medilabs (52%), Optimus Oncology (56.12%), and 7Med India (41.23% with a contracted path to majority), while Safetrunk Services was struck off in May 2025 and a merger of Humain Healthtech into the parent is in process.